单侧声带麻痹患者嗓音障碍指数-10的最小临床重要差异
结果显示VHI-10改善的MCID为下降4分,ROC曲线下面积为0.80,敏感度和特异度分别为0.62和0.88。
要点
- 单侧声带麻痹患者VHI-10改善的MCID为下降4分。
- ROC曲线下面积0.80,敏感度0.62,特异度0.88。
- VHI-10变化评分可区分改善与无改善。
核心结论
- 单侧声带麻痹患者VHI-10改善的最小临床重要差异为下降4分。
主要发现
- 总体VHI-10平均变化为-3.71(SD=8.89),整体变化评分平均为1.37(SD=2.51)。
- 整体变化评分指示改善、无变化和恶化的患者VHI-10平均变化分别为-7.45、-0.53和+4.40,组间差异有统计学意义(P<.001)。
- ROC曲线下面积为0.80,VHI-10变化-4分为区分改善与无改善的最佳阈值,敏感度和特异度分别为0.62和0.88。
关键数值与推荐
- VHI-10改善的MCID为下降4分(基于ROC曲线分析,敏感度0.62,特异度0.88)。
- 临床共识曾定义有意义的改善为下降≥5分。
临床怎么用
- 临床中可使用VHI-10下降4分作为单侧声带麻痹患者治疗有效的判断阈值。
- 该MCID有助于理解患者对治疗的反应并比较不同治疗效果。
局限性
- 研究证据等级为4级。
- 未来研究需确定VHI-10在所有嗓音障碍中的MCID。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: The Voice Handicap Index-10 (VHI-10) is commonly used to measure patients' perception of vocal handicap. Clinical consensus has previously defined clinically meaningful improvement as a decrease ≥5. This study determines the minimal clinically important difference (MCID) for VHI-10 in patients with unilateral vocal fold paralysis (UVFP) using anchor-based methodology. STUDY DESIGN: Prospective cohort questionnaire analysis. METHODS: Two hundred eighty-one UVFP patients completed the VHI-10 on two consecutive visits (within 3 months). At the follow-up visit, patients answered an 11-point Global Rating of Change Questionnaire (GRCQ) scored from -5 to +5. Relationship between the GRCQ and change in VHI-10 was quantified using analysis of variance, and MCID for the VHI-10 was determined using receiver operating characteristic (ROC) curve analysis. RESULTS: Overall mean VHI-10 change was -3.71 (standard deviation [SD] = 8.89) and mean GRCQ was 1.37 (SD = 2.51). Average interval between measurements was 1.73 months (SD = 0.83). Mean changes in VHI-10 scores were -7.45, -0.53, and +4.40 for patients whose GRCQ scores indicated improvement, no change, and worsening, respectively. Differences between mean scores were statistically significant (P < .001). Area under the ROC curve was 0.80, demonstrating the classification accuracy of VHI-10 change scores. A VHI-10 change of -4 was determined to be the optimal threshold that discriminated between improvement and no improvement (sensitivity and specificity 0.62 and 0.88, respectively). CONCLUSIONS: The MCID for improvement in VHI-10 in UVFP patients is a decrease of 4. This information improves understanding of patients' response to treatment and allows comparison between different treatments. Future research should determine MCID for VHI-10 across all voice disorders. LEVEL OF EVIDENCE: 4. Laryngoscope, 128:1419-1424, 2018.
引用
- Young VN, Jeong K, Rothenberger SD, et al. Minimal clinically important difference of voice handicap index-10 in vocal fold paralysis. Laryngoscope. 2017. PMID: 29219184. doi:10.1002/lary.27001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。